BLOG
Join the Conversation
Cannabis Industry Update 10.26.18
The Latest in Medical Cannabis Research: Fall 2018 The third quarter of this year was full big headlines for the cannabis industry. Epidiolex became the first cannabis-based medicine to gain FDA-approval in the United States, Coca-Cola and Budweiser are preparing to...
Markets and Economics Update 10.26.18
1987 All Over Again? Here’s the Data As tempting as it is to call a bottom for the current flush in US equities, we will hold off for one reason, even if it is an outlier probability: markets crash when they are already oversold. That might seem counterintuitive, but...
Cryptocurrency Update 10.25.18
CCN: Shark Tank’s Kevin O’Leary Invests $100,000 in Bitcoin Investing App Of Shark Tank’s investor lineup, Mark Cuban is the most likely to invest in blockchain technologies. However, already having money in several including the untraceable messaging platform Dust...
Cannabis Stocks Are Plunging – Time to Sell?
So what were you thinking, getting into these high-beta stocks? If you’re not familiar with the term “high-beta,” it refers to stocks that are expected to be more volatile than the average. Of course, given the sell-offs we’ve been seeing across the broader market,...
Cryptocurrency Update 10.22.18
Crypto M&A is on a tear as deal-makers see opportunity in bitcoin's price slump Deal-makers seem to be anything but deterred by bitcoin’s price pain this year — they’re actually using it as an excuse to go bargain hunting. Despite the ongoing bear market in the...
Cannabis Industry Update 10.22.18
Trump Signals Support for Legislation Easing US Ban on Marijuana President Donald Trump said Friday that he's inclined to support a bipartisan effort in Congress to ease the U.S. ban on marijuana, a proposal that would dramatically reshape the nation's legal landscape...
Markets and Economics Update 10.22.18
Their money worthless, Venezuela's desperate flee by foot "As night approached, Sandra Cadiz wrapped her shivering daughter in a blanket and prayed for a ride up the frigid Colombian mountaintop known as 'the icebox.' Ten-year-old Angelis already had on nearly all of...
Cannabis Stock Price Analysis: The Green Organic Dutchman
The Green Organic Dutchman (TGODF) For a stock that looked for a moment like it was taking off, it’s hard not to say that the price action looks exceedingly bearish. With a clear downtrend setup starting at (1), the support level at (2) is critical, as breaking below...
Cannabis Stock Price Analysis: Innovative Industrial Properties
Innovative Industrial Properties, Inc (IIPR) We've barely touched upon IIPR in this forum, but it makes for an interesting cannabis play as a REIT that focuses on acquiring and leasing out industrial properties for cannabis production. With the volume behind it...
Cannabis Stock Price Analysis: GW Pharmaceuticals
GW Pharmaceuticals (GWPH) Was the period between Sept 20 and 28 a market overreaction? Either case, GWPH finds itself once again in the range that preceded it, with resistance (1) at 149.40 and support (2) at 137.27. A steep short-term downtrend couched within a...
The risk of loss in trading stocks, options, foreign equities, and bonds can be substantial and is not suitable for all investors. Trading on margin is not suitable for all investors and losses exceeding your initial deposit is possible. Supporting documentation is available upon request. Day trading is high risk, speculative trading strategy and not suitable for all investors. Carefully consider whether trading is suitable for you in light of your circumstances, knowledge, and financial resources and only risk capital should be used. You are fully responsible for any investment decision you make. Halifax America does not make investment recommendations and does not provide tax, financial, or legal advice.
Partners and regulatory bodies
